Skip to main content
Facebook
Twitter
LinkedIn
Home
Mobile menu expand icon Menu Close
  • Products
    • Catalog
    • Books
    • Journals
    • LD Connect
  • Services
    • Authors
    • Librarians
    • Reviewers
    • Policies
  • Initiatives
    • Open Science
    • Sustainability
    • Partnerships
    • R&D
    • Labs
  • About
    • Company Story
    • Core Values
    • Memberships
    • News
  • Contact
Lorraine Kalia

Breadcrumb

  1. Home
  2. News
  3. Journal of Parkinson’s Disease Welcomes New Co-Editor-in-Chief Lorraine V. Kalia, MD, PhD, FRCPC

Journal of Parkinson’s Disease Welcomes New Co-Editor-in-Chief Lorraine V. Kalia, MD, PhD, FRCPC

20 May 2022
Neurosciences
Neurosciences
Share this News article

Amsterdam, NL – The Journal of Parkinson’s Disease (JPD), published by IOS Press, is pleased to announce the appointment of new co-Editor-in-Chief, Lorraine V. Kalia, MD, PhD, FRCPC. Dr. Kalia joins co-Editor-in-Chief Bas Bloem, MD, PhD, FRCPE, and an eminent international editorial board, who are dedicated to the continuing success of the world’s leading journal in Parkinson’s research.

Lorraine Kalia
Lorraine V. Kalia, MD, PhD, FRCPC

 A globally recognized authority on Parkinson’s disease, Lorraine V. Kalia, MD, PhD, FRCPC, is an Associate Professor and Clinician Scientist in the Division of Neurology at the University of Toronto and a Senior Scientist at the Krembil Research Institute of the University Health Network. She holds appointments with the University of Toronto’s Tanz Centre for Research in Neurodegenerative Diseases and Department of Laboratory Medicine and Pathobiology. She is also a Staff Neurologist in the Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease at the Toronto Western Hospital, University Health Network. 

Dr. Kalia serves as Co-Chair of the Scientific Issues Committee and a Steering Committee Member of the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society. Her clinical work and research program focus on Parkinson’s disease and related movement disorders. With an eye always on the clinic, she heads a research team focused on elucidating the critical molecular mechanisms responsible for neurodegeneration in Parkinson’s disease and identifying therapeutic agents that can target these molecular mediators of neurodegeneration. 

Dr. Kalia’s appointment follows the departure of one of JPD’s founding editors, Patrik Brundin, MD, PhD, who has moved out of academia and is now Therapeutic Area Leader for Movement Disorders at Roche Pharmaceutical Research and Early Development. Dr. Brundin served as co-Editor-in-Chief for 12 years, from its days as a fledging journal to its current position as a leading publisher of groundbreaking Parkinson’s research. He looks forward to seeing the journal’s continued growth and success.

Dr. Kalia commented, “I am excited to be stepping into the role of co-Editor-in-Chief, although I appreciate that Patrik’s shoes are very large ones to fill. Bas and Patrik have done incredible work for the journal, increasing its reach and impact over the past few years. I look forward to working with Bas and the team to maintain this positive trajectory by further developing the journal as a unique open forum for excellent research into Parkinson's that also includes the voice of those affected by the disease.” 

“I could not be more thrilled that Lorraine Kalia has consented to join JPD as the new co-Editor-in-Chief,” added Dr. Bloem, Radboud University Nijmegen Medical Centre. “Dr. Kalia has an outstanding track record in the field of Parkinson research, and she is a wonderful colleague to work with. She and I are already working on plans to take our journal to the next level, so please stay tuned for more information soon!”

JPD header (with EICs)

###

NOTES FOR EDITORS

Contact
To request additional information, contact the executive publisher of the journal, Rasjel van der Holst, IOS Press (r.van.der.holst@iospress.nl). 

About the Journal of Parkinson’s Disease
The Journal of Parkinson’s Disease (JPD) is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal is international and multidisciplinary and aims to promote progress in the epidemiology, etiology, genetics, molecular correlates, pathogenesis, pharmacology, psychology, diagnosis, and treatment of Parkinson’s disease. It publishes research reports, reviews, short communications, and letters-to-the-editor and offers very rapid publication and an affordable open access option. JPD has a 2020 Journal Impact Factor of 5.568 according to Journal Citation Reports (Clarivate, 2021) and is published by IOS Press. journalofparkinsonsdisease.com 

About IOS Press
IOS Press is an independent international scientific, technical, medical (STM) publishing house established in 1987 in Amsterdam. We produce around 90 journals and 70 books annually in a broad range of subject categories, primarily specializing in biomedical and life sciences (including neurosciences, medical informatics, cancer research, rehabilitation) and physical sciences (including computer sciences, artificial intelligence, engineering). In addition, we offer specialized services that support scientific advancement. iospress.com
 

Related news items

green JAD cover on a pale green background with blue dots behind the cover
9 March 2023

Researchers from Rowan University and Durin Technologies announce highly accurate blood test for Alzheimer’s Disease

Stratford, NJ, USA - A team of researchers from Rowan-Virtua School of Osteopathic Medicine (Rowan-Virtua SOM) and Durin Technologies, Inc., have announced the...

Read more
green JAD cover on a pale green background with blue dots behind the cover
3 February 2023

In patients with mild cognitive impairment, apathy can be a predictor of Alzheimer’s disease

Houston, USA - The presence of apathy in patients with mild cognitive impairment is strongly linked to a progression to Alzheimer’s disease, giving physicians a...

Read more
green JAD cover on a pale green background with blue dots behind the cover
31 January 2023

Do Sleep Medications Increase Your Chances of Dementia?

San Francisco, USA – A new study shows that sleep medications increase the risk of dementia in whites. But the type and quantity of the medication may be...

Read more

Subscribe To Our Quarterly Newsletter

Home

Accelerate Research. Increase Impact.

© IOS Press

View News View Catalog

Legal

  • Disclaimer
  • Privacy Policy

Menu

  • About
  • News
  • Catalog
  • Initiatives
  • Products
  • Services

Quick Links

  • Publish With Us
  • Sustainability & SDGs
  • Open Library
  • Policies
  • Sitemap
  • FAQs

Contact

IOS Press

Nieuwe Hemweg 6B

1013 BG Amsterdam

the Netherlands

iospress.com

Contact Us
Facebook
Twitter
LinkedIn
© IOS Press 2023 - Terms of use - Privacy policy
Powered by Dropsolid